DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 7Dr. Reddy's Laboratories
02 1NanoAlvand
03 3Ever Pharma
04 1medac
05 3Advanz Pharma
06 2Baxter Healthcare Corporation
07 3Bayer AG
08 2Chia Tai Tianqing Pharmaceutical Group
09 10Eisai
10 4Eisai Inc
11 1GLAND PHARMA LIMITED
12 2GSK
13 2Glenmark Pharmaceuticals
14 1Hikma Pharmaceuticals
15 1JIANGXI KVVIT PHARM
16 1Long Grove Pharmaceuticals
17 1Natco Pharma (Canada) Inc
18 4STADA Arzneimittel
19 1Sandoz B2B
20 1Viatris
21 2Yes Pharmaceutical Development Services Gmbh
22 2Zentiva
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 22Injectable Solution
04 1Injection
05 3SOLUTION
06 9SOLUTION;INTRAVENOUS
07 8Solution For Injection
08 1Solution for Injection
09 1Solution for injection
10 8Blank
01 1Allowed
02 10Approved
03 10Authorized
04 1Cancelled
05 1Lead Market Dossiers- Filed
06 4Marketed
07 1Originator
08 7Prescription
09 9RX
10 11Blank
01 8ERIBULIN MESYLATE
02 1ERIBULIN MESYLATE INJECTION
03 1Eribulin
04 3Eribulin Advanz Pharma
05 4Eribulin Baxter
06 4Eribulin Dr.Reddy's
07 1Eribulin Ever Pharma
08 2Eribulin Glenmark
09 1Eribulin Medac
10 3Eribulin Stada
11 1Eribulin Stada Arzneimittel Ag
12 1Eribulin Zentiva
13 1Eribulina Cttq
14 1Eribulina Ever Pharma
15 1Eribulina Glenmark
16 1Eribulina Hikma
17 1Eribulina Viatris
18 1Eribulina Zentiva
19 2HALAVEN
20 1Halave
21 11Halaven
22 2Mevlyq
23 1NAT-ERIBULIN
24 1Nibulin®
25 1Blank
01 8Australia
02 1Austria
03 3Canada
04 4Estonia
05 1India
06 1Iran
07 1Italy
08 4Norway
09 1South Africa
10 11Spain
11 10Sweden
12 1Switzerland
13 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 217473
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Nibulin®
Dosage Form : Solution for Injection
Dosage Strength : 1MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 07/06/2024
Application Number : 20221221000240
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Medac
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000183
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ERIBULIN MESYLATE INJECTION
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number : 2545950
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Eribulin Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Eribulin Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Eribulin Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Eribulin Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name : Eribulin
Dosage Form : Solution for injection
Dosage Strength : 0.44MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eribulina Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44MG
Packaging :
Approval Date : 30-09-2024
Application Number : 89838
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-03-04
Application Number : 218743
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-08-05
Application Number : 218142
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-06-09
Application Number : 214310
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
